Safety of escitalopram in pregnancy: A case series

Neuropsychiatric Disease and Treatment

Volumn 9, Issue , 2013, Pages 1333-1337

  Bellantuono, Cesario ^a   Bozzi, Francesca ^a   Orsolini, Laura ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Breastfeeding; Escitalopram; Major malformations; Perinatal complications; Pregnancy

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE; CLONAZEPAM; ESCITALOPRAM; LEVOTHYROXINE; LORAZEPAM; PAROXETINE;

ADULT; ANXIETY; APGAR SCORE; ARTICLE; BREAST FEEDING; CASE STUDY; CLINICAL ARTICLE; CLINICAL FEATURE; CONGENITAL MALFORMATION; DEMOGRAPHY; DRUG EXPOSURE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG USE; DRUG WITHDRAWAL; DSM-IV; FEMALE; GENERALIZED ANXIETY DISORDER; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HUMAN; LOW DRUG DOSE; MAJOR DEPRESSION; PANIC; PATIENT SELECTION; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PSYCHIATRIC DIAGNOSIS; PUERPERAL DEPRESSION; SIDE EFFECT; SPONTANEOUS ABORTION;

EID: 84884371954     PISSN: 11766328     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S45951     Document Type: Article

References (13)

1. Birndorf CA, Madden A, Portera L, Leon AC. Psychiatric symptoms, functional impairment, and receptivity toward mental health treatment among obstetrical patients. Int J Psychiatry Med. 2001;31(4): 355-365.
2. Grant BF, Goldstein RB, Chou SP, et al. Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Mol Psychiatry. 2009;14(11):1051-1066.
3. Yonkers KA, Wisner KL, Stewart DE, et al. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Gen Hosp Psychiatry. 2009;31(5):403-413.
4. Cohen LS, Altshuler LL, Harlow BL, et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA. 2006;295(5):499-507.
5. Bellantuono C, Bozzi F, Orsolini L, Catena-Dell'Osso M. The safety of escitalopram during pregnancy and breastfeeding: a comprehensive review. Hum Psychopharmacol. 2012;27(6):534-539.
6. Einarson A, Choi J, Einarson TR, Koren G. Incidence of major malformations in infants following antidepressant exposure in pregnancy: results of a large prospective cohort study. Can J Psychiatry. 2009;54(4): 242-246.
7. Klieger-Grossmann C, Weitzner B, Panchaud A, et al. Pregnancy outcomes following use of escitalopram: a prospective comparative cohort study. J Clin Pharmacol. 2012;52(5):766-770.
8. Diav-Citrin O, Ornoy A. Selective serotonin reuptake inhibitors in human pregnancy: to treat or not to treat? Obstet Gynecol Int. 2012; 2012:698947.
9. Jefferies AL; Canadian Paediatric Society, and Fetus and Newborn Committee. Selective serotonin reuptake inhibitors in pregnancy and infant outcomes. Paediatric Child Health. 2011;16(9):562-563.
10. Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet. 2009;373(9665):746-758.
11. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-1-CV). New York, NY: Biometrics Research Department, New York State Psychiatric Institute, Department of Psychiatry, Columbia University; 1995.
12. Kallen BA, Otterblad OP. Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infact congenital malformations. Birth Defects Res A Clin Mol Teratol. 2007;79(4):301-308.
13. Tixier H, Feyeux C, Girod S, et al. Acute voluntary intoxication with selective serotonin reuptake inhibitors during the third trimester of pregnancy: therapeutic management of mother and fetus. Am J Obstet Gynecol. 2008;199(5):e9-e12.